Dr. James E. Crowe, Jr: Human Monoclonal Antibodies for SARS-CoV-2

In this inaugural Global COVID Lab Meeting, Dr. James E. Crowe, Jr., Director of the Vanderbilt Vaccine Center, presents an overview of his efforts to advance human monoclonal antibody therapeutics for SARS-CoV-2. Dr. Crowe’s lab is one of the leading groups globally working on antibody identification, and is targeting starting clinical studies early this summer for SARS-CoV-2 therapeutics.